Peetz Christopher
SEC CIK 1614740 · EDGAR
BoughtSold
Most active insiders at MIRM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peetz Christopher | CEO, Dir | — | $16.29M |
| 2 | GREY MICHAEL G | Dir | — | $11.10M |
| 3 | Heron Patrick J | Dir | $9.00M | — |
| 4 | Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| 5 | BJERKHOLT ERIC | CFO | — | $3.56M |
| 6 | Radovich Peter | Pres AND COO | — | $2.32M |
| 7 | Ramasastry Saira | Dir | — | $1.92M |
| 8 | Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| 9 | Cardon Lon | Dir | — | — |
| 10 | Fischer Laurent | Dir | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 18:52 | 2026-09-01 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +30.0K | 224.4K | +15% | +$88.1K |
| DMT | 2026-09-03 18:52 | 2026-09-01 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $98.68 | -30.0K | 194.4K | -13% | -$2.96M |
| DT | 2026-08-11 17:41 | 2026-08-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +20.0K | 214.3K | +10% | +$58.7K |
| DMT | 2026-08-11 17:41 | 2026-08-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $98.92 | -20.0K | 194.3K | -9% | -$1.98M |
| D | 2026-07-17 16:07 | 2026-07-15 | ARQT | Arcutis Biotherapeutics, Inc. | Peetz Christopher | Dir | A - Grant | $0.00 | +4,315 | 4,315 | New | $0 |
| DT | 2026-07-08 17:12 | 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +20.0K | 214.3K | +10% | +$58.7K |
| DMT | 2026-07-08 17:12 | 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $122.27 | -20.0K | 194.3K | -9% | -$2.45M |
| DT | 2026-06-02 19:50 | 2026-06-01 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +30.0K | 224.3K | +15% | +$88.1K |
| DMT | 2026-06-02 19:50 | 2026-06-01 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $95.84 | -30.0K | 194.3K | -13% | -$2.88M |
| DM | 2026-03-17 | 2026-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | — | +75.0K | 235.3K | +47% | — |
| D | 2026-03-17 | 2026-03-16 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $91.98 | -41.0K | 194.3K | -17% | -$3.77M |
| 2026-02-03 | 2026-02-02 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale | $103.30 | -9,108 | 160.3K | -5% | -$940.9K | |
| D | 2026-01-27 | 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | — | +12.5K | 176.2K | +8% | — |
| D | 2026-01-27 | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $96.19 | -6,831 | 169.4K | -4% | -$657.1K |
| D | 2026-01-23 | 2026-01-21 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | — | +12.8K | 170.8K | +8% | — |
| D | 2026-01-23 | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $93.33 | -7,098 | 163.7K | -4% | -$662.5K |
| I | 2026-01-02 | 2025-12-31 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | G - Gift | $0.00 | -21.1K | 187.5K | -10% | $0 |
| D | 2025-11-20 | 2025-11-18 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $19.24 | +19.1K | 158.0K | +14% | +$368.1K |
| D | 2025-08-12 | 2025-08-11 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $62.00 | -40.0K | 138.6K | -22% | -$2.48M |
| D | 2025-08-12 | 2025-08-11 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +40.0K | 178.6K | +29% | +$117.6K |
| D | 2025-08-08 | 2025-08-07 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $55.25 | -40.0K | 138.6K | -22% | -$2.21M |
| D | 2025-08-08 | 2025-08-07 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +40.0K | 178.6K | +29% | +$117.6K |
| D | 2025-03-18 | 2025-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | — | +50.0K | 165.9K | +43% | — |
| D | 2025-03-18 | 2025-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $44.21 | -27.3K | 138.6K | -16% | -$1.21M |
| DM | 2025-03-04 | 2025-03-03 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $46.91 | -40.0K | 115.9K | -26% | -$1.88M |
| D | 2025-03-04 | 2025-03-03 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +40.0K | 155.9K | +35% | +$117.6K |
| 2025-02-04 | 2025-02-03 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale | $48.22 | -9,102 | 115.9K | -7% | -$438.9K | |
| D | 2025-01-27 | 2025-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | — | +12.5K | 131.9K | +10% | — |
| D | 2025-01-27 | 2025-01-24 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale+OE | $47.92 | -6,837 | 125.0K | -5% | -$327.6K |
| 2025-01-08 | 2025-01-07 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale | $42.82 | -7,489 | 119.4K | -6% | -$320.7K | |
| 2024-11-14 | 2024-11-08 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | A - Grant | $21.05 | +65 | 126.8K | +0.1% | +$1,368 | |
| D | 2024-07-24 | 2024-07-23 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +34.0K | 126.8K | +37% | +$100.0K |
| 2024-05-16 | 2024-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | A - Grant | $21.05 | +817 | 92.8K | +0.9% | +$17.2K | |
| 2024-03-18 | 2023-01-09 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale | $20.62 | -5,159 | 92.0K | -5% | -$106.4K | |
| 2024-02-05 | 2024-02-02 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO, Dir | S - Sale | $26.19 | -6,013 | 104.1K | -5% | -$157.5K | |
| 2024-01-09 | 2024-01-08 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres AND CEO, Dir | S - Sale | $28.03 | -5,209 | 110.1K | -5% | -$146.0K | |
| 2023-07-05 | 2023-07-03 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | S - Sale | $25.65 | -5,498 | 115.3K | -5% | -$141.0K | |
| 2023-05-19 | 2023-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $16.92 | +1,256 | 120.8K | +1% | +$21.3K | |
| D | 2023-02-02 | 2023-01-31 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +50.0K | 119.6K | +72% | $0 |
| 2022-11-14 | 2022-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $17.05 | +49 | 69.6K | +0.1% | +$835.45 | |
| 2022-05-12 | 2022-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $13.57 | +1,500 | 69.5K | +2% | +$20.4K | |
| D | 2022-01-07 | 2022-01-06 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 68.0K | +143% | $0 |
| 2021-11-29 | 2021-11-24 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | P - Purchase | $14.40 | +7,000 | 28.0K | +33% | +$100.8K | |
| 2021-10-01 | 2021-09-29 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +21.9K | 24.7K | +775% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Pres, CEO, Dir | S - Sale | $19.26 | -3,672 | 21.0K | -15% | -$70.7K |
Purchase Sale Sale after option exercise All abbreviations